Shire Agrees to FDA Request to Test ADHD Medication on Preschool Children

Shire, a global innovator in specialty biopharmaceuticals, announced today that they will conduct clinical trials using their amphetamine-based drug, Vyvanse, on preschool children with attention deficit hyperactivity disorder (ADHD). Like Us on Facebook ...



from Meta Search Alerts http://ift.tt/1kCi8Xx

via IFTTT